Hybridomas: a potent new biotechnology.
D000818:Animals; D000918:Antibody Specificity; D002999:Clone Cells / Q000276:immunology*; D004345:Drug Industry / Q000191:economics; D006801:Humans; D006822:Hybrid Cells / Q000276:immunology*; D007158:Immunologic Techniques; D007449:Investments; D051379:Mice; D009194:Myeloma Proteins / Q000276:immunology; D010330:Patents as Topic; D010954:Plasmacytoma / Q000276:immunology; D012106:Research
D009194:Myeloma Proteins